athenahealth, Inc. (NASDAQ:ATHN) had its price target trimmed by Jefferies Group LLC from $135.00 to $120.00 in a report released on Friday. The brokerage currently has a hold rating on the health services provider’s stock. Jefferies Group also issued estimates for athenahealth’s Q3 2017 earnings at $0.25 EPS.

Several other research analysts also recently commented on ATHN. Evercore ISI reiterated an outperform rating and issued a $147.00 target price (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. Leerink Swann set a $140.00 target price on shares of athenahealth and gave the stock a hold rating in a report on Friday, May 19th. Robert W. Baird set a $140.00 target price on shares of athenahealth and gave the stock a buy rating in a report on Thursday, May 18th. Cantor Fitzgerald reiterated an overweight rating and issued a $140.00 target price (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. Finally, Oppenheimer Holdings, Inc. reiterated an outperform rating and issued a $154.00 target price (up previously from $119.00) on shares of athenahealth in a report on Monday, May 22nd. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have given a buy rating to the stock. athenahealth currently has a consensus rating of Hold and a consensus target price of $149.77.

athenahealth (NASDAQ:ATHN) opened at 128.94 on Friday. athenahealth has a 52-week low of $90.11 and a 52-week high of $158.66. The firm has a 50-day moving average of $139.00 and a 200-day moving average of $128.87. The stock has a market capitalization of $5.15 billion, a PE ratio of 163.63 and a beta of 1.79.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, topping the consensus estimate of $0.39 by $0.12. The firm had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The business’s quarterly revenue was up 15.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.34 EPS. On average, equities analysts expect that athenahealth will post $1.91 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/09/18/jefferies-group-llc-trims-athenahealth-inc-athn-target-price-to-120-00.html.

In related news, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.81, for a total transaction of $112,648.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.52, for a total transaction of $562,080.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $44,939,279.64. The disclosure for this sale can be found here. Insiders have sold a total of 15,422 shares of company stock valued at $2,182,607 over the last three months. 3.20% of the stock is currently owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Turner Investments LLC bought a new position in athenahealth during the 2nd quarter valued at about $105,000. FNY Partners Fund LP lifted its holdings in athenahealth by 1,900.0% during the 1st quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after purchasing an additional 950 shares during the last quarter. Bessemer Group Inc. lifted its holdings in athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 113 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the last quarter. Finally, Seven Bridges Advisors LLC lifted its holdings in athenahealth by 5.4% during the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after purchasing an additional 67 shares during the last quarter.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.